triamcinolone has been researched along with Optic Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartz-Schmidt, KU; Jaissle, GB; Szurman, P | 1 |
| Jackson, FE | 1 |
2 other study(ies) available for triamcinolone and Optic Atrophy
| Article | Year |
|---|---|
[Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling].
Topics: Aged; Anti-Inflammatory Agents; Basement Membrane; Crystallization; Epiretinal Membrane; Follow-Up Studies; Humans; Injections; Male; Optic Atrophy; Retinal Perforations; Scotoma; Triamcinolone; Visual Acuity; Visual Fields; Vitrectomy; Vitreous Body | 2008 |
Optic chiasmatic arachnoiditis: improvement of rapidly failing vision following surgical lysis of chiasmatic adhesions and postoperative steroid therapy.
Topics: Adult; Arachnoiditis; Female; Frontal Lobe; Humans; Optic Atrophy; Optic Neuritis; Papilledema; Scotoma; Steroids; Syndrome; Tissue Adhesions; Triamcinolone; Visual Fields | 1974 |